Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

The mK6irs1/Krt2-6g gene likely causes wavy hair in mice.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

Cancer prevention has advanced significantly, with some strategies proving successful.

Blocking Hedgehog signaling offers new treatment options for advanced basal cell carcinoma.

Gene variation affects prostate issues and hair loss.

Mutations in the AR gene cause hair thinning and loss.

Targeting the TNFRSF1B gene may help treat hair loss.

Androgen receptors help prostate cancer cells grow and resist drugs.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Injury boosts normal skin cell growth, reducing cancer cell advantage.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

A specific mutation known for causing cancer is also found to cause a skin condition in a young girl.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Targeting Keratin 17 may help overcome cancer therapy resistance.

CEC levels may be a useful marker for predicting prostate cancer progression.